Evotec SE
EVOTF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesEVO
Q3 2022 vs. Q2 2022
How the institutions holding Evotec SE changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 11.5K | 0 | −11.5K (−100.0%) |
| Value | $316.0K | $0 | −$316.0K (−100.0%) |
New holders (0)
Institutions that held Evotec SE at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (1)
Institutions that held Evotec SE at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 11,458 | $316.0K |